Alejandro González Veliz: Cardiology Enters the Era of Inflammation
Alejandro González Veliz, Interventional Cardiologist at Institute of Cardiology and Cardiovascular Surgery, shared a post on LinkedIn:
“Cardiology is changing.
And inflammation may be one of the biggest reasons why.
For decades, cardiovascular risk was centered around:
- LDL cholesterol
- stenosis severity
- ischemia
But many patients continue to experience cardiovascular events despite ‘optimal’ lipid control.
Why?
Because atherosclerosis is not only a lipid disease.
It is also a chronic inflammatory disease.
Inflammation influences:
- endothelial dysfunction
- plaque formation
- plaque vulnerability
- thrombosis
- residual cardiovascular risk
This evolving paradigm is reshaping modern preventive cardiology.
Today, inflammation is increasingly connected to:
- hs-CRP
- obesity
- insulin resistance
- metabolic disease
- PCOS
- GLP-1 therapies
- residual inflammatory risk
The future of cardiovascular prevention may become far more personalized:
- ApoB
- Lp(a)
- inflammatory profiling
- metabolic health
- vascular biology
The question is no longer only:
‘How severe is the stenosis?’
The question is becoming:
‘How biologically active is the disease?’
Cardiology is entering the era of inflammation.”

Stay updated with Hemostasis Today.
-
Jul 13, 2026, 23:39Yaariv Khaykin: Whole-Person Care Can Strengthen Stroke Prevention in Patients With Atrial Fibrillation
-
Jul 13, 2026, 22:33ESOC 2026 recordings are now available on eSTEP – European Stroke Organisation
-
Jul 13, 2026, 20:17Julia R. Coleman: Fantastic First Day at ISTH 2026
-
Jul 13, 2026, 20:11Ruah Alyamany: Combination Therapy Improves Quality of Life in ITP
-
Jul 13, 2026, 19:47Brian O Mahony: Two-Year Results of BBM-H901 Gene Therapy Presented at ISTH 2026
-
Jul 13, 2026, 19:37Sara Zalghout: Connecting With Colleagues From All Over the World at ISTH 2026
-
Jul 13, 2026, 18:54Alfonso J. Tafur: New Evidence on Perioperative Anticoagulation in Cancer at ISTH 2026
-
Jul 13, 2026, 18:42Jessica Garcia: Thrombin Generation in Type 3 VWD With an Inhibitor on Emicizumab
-
Jul 13, 2026, 18:19Fionnuala Ní Áinle: High-Quality Evidence for DVT Diagnosis in Pregnancy at ISTH 2026